Chemotherapy of advanced ovarian cancer: Current status and future directions

Seminars in Oncology

Volumn 24, Issue 1 SUPPL. 2, 1997, Pages

  Ozols, R F ^a   Vermorken, J B ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PACLITAXEL;

CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; META ANALYSIS; OVARY CANCER; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; UNITED STATES;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; CLINICAL TRIALS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; OVARIAN NEOPLASMS; PACLITAXEL;

EID: 0031052436     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (49)